Unichem Laboratories' formulations manufacturing facility at Goa has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA).

This receipt indicates the successful closure of the inspection and the queries raised during the audit (Form 483). The inspection has now been closed by the USFDA. The inspection was carried out between March 14, 2017 to March 20, 2017.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Shares of the company gained Rs 7.15, or 2.75%, to trade at Rs 267.25. The total volume of shares traded was 7,867 at the BSE (10.09 a.m., Friday).